Longevity Health Holdings, Inc. (XAGE) Fair Value 2026

XAGE · Household & Personal Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.7 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (42/100)

Quick Summary — As of 2026-08-27, Longevity Health Holdings, Inc. (XAGE) trades at $0.21. QOC: 4.7/10. Value Trap Risk: 42/100 (WARN). 1/13 models active.

Key Facts

Ticker
XAGE
Price
$0.21
Quality Score
4.7/10
Value Trap Risk
42/100
Models Active
1/13
Last Updated
Strength: PWERM suggests +65.4% upside with 34% confidence
Risk: Value Trap score of 42 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give XAGE?

1 Intrinsic Value Models vs. Current Price ($0.21)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $0.35 +65.4%

All Models Active

All 1 models are displayed above.

What Is Longevity Health Holdings, Inc. (XAGE) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Longevity Health Holdings, Inc. is potentially undervalued at its current price of $0.21. Based on our 13-model framework, Longevity Health Holdings, Inc.'s intrinsic value is estimated at a median fair value of $0.35 — representing +65.4% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About XAGE?

1 of 13 models are currently active for XAGE. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does XAGE Rank in Household & Personal Products?

Among 35 Household & Personal Products stocks, XAGE ranks #29 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.

As a consumer-facing company, Longevity Health Holdings, Inc. operates in a sector where same-store sales growth (comps) is a critical driver of valuation. Investors evaluating XAGE should weigh these sector-specific dynamics alongside our model-derived fair values.

Is XAGE a Value Trap?

CirclFi's Value Trap algorithm assigns XAGE a score of 42/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Longevity Health Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Longevity Health Holdings, Inc.'s fundamental quality profile registers 4.7/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every XAGE valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across XAGE's 1 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Longevity Health Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Household & Personal Products Stocks Should You Also Analyze?

10 related Household & Personal Products stocks with 13-model coverage

PUREPURE Bioscience, Inc.QOC 5.4GROVGrove Collaborative Holdings, Inc.QOC 4.7WALDWaldencast plcQOC 5.7SKVISkinvisible, Inc.QOC 4.4SKINSkinHealth Systems Inc.QOC 6.0ADTIAdapti, Inc.QOC 3.1PGThe Procter & Gamble CompanyQOC 8.8SPBSpectrum Brands Holdings, Inc.QOC 7.7HELEHelen of Troy LimitedQOC 6.6IPARInterparfums, Inc.QOC 9.3

Read investment analysis: PURE · GROV · WALD · SKVI · SKIN · ADTI · PG · SPB · HELE · IPAR

Which Other Stocks Have a Similar Quality Score to XAGE?

7 companies across all industries closest to XAGE’s Quality of Company score of 4.7/10.

GEMIGemini Space Station, Inc.QOC 4.7ZPTAZapata Quantum, Inc.QOC 4.7OWPCOne World Products, Inc.QOC 4.7YHCLQR House Inc.QOC 4.7SVRNOceanPal Inc.QOC 4.7PLAGPlanet Green Holdings Corp.QOC 4.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: GEMI · ZPTA · OWPC · YHC · SVRN · PLAG · NVDA

What Else Do Investors Ask About Longevity Health Holdings, Inc.’s Valuation?

What is Longevity Health Holdings, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Longevity Health Holdings, Inc. (XAGE). The Quality of Company score is 4.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is XAGE overvalued or undervalued right now?

At $0.21, 1 of 1 active models suggest XAGE may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Longevity Health Holdings, Inc.'s business model in Household & Personal Products.

What does a Quality of Company score of 4.7 mean for XAGE?

Longevity Health Holdings, Inc.'s QOC of 4.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on XAGE?

CirclFi analyzes XAGE with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is XAGE a value trap in 2026?

Longevity Health Holdings, Inc.'s Value Trap score is 42/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Longevity Health Holdings, Inc. (XAGE) a Quality of Company score of 4.7/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/XAGE/ · Methodology
Primary sources for this XAGE valuation
  • Financial statements: Longevity Health Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001842939) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for XAGE as of ; valuations recomputed .